18-Sep-2026
10 large and mega-cap U.S. healthcare stocks with the strongest momentum grades
Seeking Alpha News (Thu, 17-Sep 10:00 AM ET)
Avantor Raises Guidance After Strong Q2 Free Cash Flow and Solid VWR Segment Performance
Market Chameleon (Wed, 29-Jul 7:10 AM ET)
Avantor Lifts 2026 Outlook as VWR Distribution & Services Returns to Growth and Cash Flow Surges
Market Chameleon (Wed, 29-Jul 3:09 AM ET)
Avantor Reports Second Quarter 2026 Results
PRNewswire (Wed, 29-Jul 6:05 AM ET)
PRNewswire (Tue, 14-Jul 8:05 AM ET)
Avantor to Report Second Quarter 2026 Earnings on Wednesday, July 29, 2026
PRNewswire (Wed, 1-Jul 8:05 AM ET)
Avantor’s 2025 Results Highlight Strategic Revival Amid Margin Pressure and Cash Flow Strength
Market Chameleon (Wed, 11-Feb 2:07 AM ET)
Avantor Inc provides products and services to customers in the biopharma, healthcare, education & government, and advanced technologies & applied materials industries. The company operates through two segments: Laboratory Solutions and Bioscience Production. It offers materials & consumables, equipment & instrumentation, and services & specialty procurement. Product groups include Equipment & Instrumentation, Services & Specialty Procurement, Proprietary Materials & Consumables, and Third-Party Materials & Consumables. Materials & consumables include high-purity chemicals and reagents, lab supplies, customized excipients, single-use assemblies, chromatography products, sample preparation kits, and fluid handling solutions. It operates in the Americas, Europe, and AMEA.
Avantor trades on the NYSE stock market under the symbol AVTR.
As of September 18, 2026, AVTR stock price declined to $15.52 with 13,099,124 million shares trading.
AVTR has a beta of 1.09, meaning it tends to be more sensitive to market movements. AVTR has a correlation of 0.06 to the broad based SPY ETF.
AVTR has a market cap of $10.50 billion. This is considered a Large Cap stock.
Last quarter Avantor reported $2 billion in Revenue and $.21 earnings per share. This beat revenue expectation by $83 million and exceeded earnings estimates by $.02.
In the last 3 years, AVTR traded as high as $28.00 and as low as $7.27.
The top ETF exchange traded funds that AVTR belongs to (by Net Assets): IJH, VTI, VB, VBR, VXF.
AVTR has outperformed the market in the last year with a price return of +20.7% while the SPY ETF gained +16.8%. AVTR has also outperformed the stock market ETF in the last 3 month and 2 week periods returning +62.0% and +3.7%, respectively, while the SPY returned +2.3% and -0.9%, respectively.
AVTR support price is $15.54 and resistance is $16.18 (based on 1 day standard deviation move). This means that using the most recent 20 day stock volatility and applying a one standard deviation move around the stock's closing price, stastically there is a 67% probability that AVTR shares will trade within this expected range on the day.